cagrisema phase 3 results 2025 semaglutide cagrilintide obesity drug: what the data shows Cagrilintide–semaglutide (CagriSema) versus semaglutide or

These weight loss treatments slow digestion and can cause side effects, which can delay or reduce absorption of oral medicines including the contraceptive pill

This results in a lower ability to promote receptor internalization compared with endogenous GLP-1, so it allows to have an increased GLP-1R expression on the cell surface, which translates in more robust insulinotropic properties, possibly explaining the enhanced insulin secretion (in both diabetic and not diabetic human islets), induced by TZP (19) by approximately 25% more than the one induced by only one of the two agents

A recent JAMA Surgery comparison of bariatric surgery and GLP-1 receptor agonists highlights why long-term treatment selection matters

The upregulation of glutamate-cysteine ligase, an enzyme involved in GSH synthesis, has been observed in some thalassemia patients as a compensatory response to oxidative stress

Sex and gender differences in COVID-19: An Italian local register-based study

What Is the List Price for Wegovy and Will It Impact Me